drugset / Trial / NCT04345120
Multiple Ascending Doses of SY-008 in Type 2 Diabetes Mellitus
RandomizedSequentialDouble-blindTreatment
Summary
This is a phase Ib placebo-controlled study to assess safety, tolerability, pharmacokinetics and pharmacodynamics of SY-008 after Multiple Ascending Doses in patients with Type 2 Diabetes Mellitus (T2DM).
Timeline
- Start
- 2020-06-15
- Primary completion
- 2021-12-15
- Completion
- 2021-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SY-008 | Unknown | 6 mg | Oral |
| Subject | SY-008 | Unknown | 12 mg | Oral |
| Subject | SY-008 | Unknown | 18 mg | Oral |